PRESS RELEASE

Q3 2022 — Press release

Q3 2022PDF · 8 pages337 KB
Media contact 	Investor contact
Timothy Barello, 212.299.2256 	John Peschier, 312.930.8491
Laurie Bischel, 312.648.8698 	CME-G
news@cmegroup.com
www.cmegroup.mediaroom.com
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Third-Quarter 2022 Financial Results
CHICAGO, October 26, 2022 - CME Group Inc. (NASDAQ: CME) today reported
financial results for the third quarter of 2022.
The company reported revenue of $1.2 billion and operating income of $739 million for
the third quarter of 2022. Net income was $680 million and diluted earnings per share were
$1.87. On an adjusted basis, net income was $719 million and diluted earnings per share were
$1.98. Financial results presented on an adjusted basis for the third quarter of 2022 and 2021
exclude certain items, which are detailed in the reconciliation of non-GAAP results. 1
"Our strong Q3 financial performance was driven by a 26% increase in trading volume,
generating double-digit growth in total revenue," said CME Group Chairman and Chief
Executive Officer Terry Duffy. "During the quarter, year-over-year volume rose in five of our six
asset classes, led by interest rates, equity indexes and a near-record quarter for foreign
exchange. Likewise, the demand for our products remains strong, with year-to-date volumes up
22%, as clients continue to manage risk amid global economic and geopolitical uncertainty."
Third-quarter 2022 average daily volume (ADV) was 22.4 million contracts, including
non-U.S. ADV of 6.1 million contracts, led by 41% growth in Asia, 31% in Latin America, and
14% in EMEA.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more -

-- 1 of 8 --

Page 2
Clearing and transaction fees revenue for third-quarter 2022 totaled $1.0 billion. The
total average rate per contract was $0.631. Market data revenue totaled $154 million for third-
quarter 2022.
As of September 30, 2022, the company had approximately $2.2 billion in cash
(including $100 million deposited with Fixed Income Clearing Corporation (FICC) and included
in other current assets) and $3.4 billion of debt. The company paid dividends during the third
quarter of approximately $363 million. The company has returned over $18.8 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss third-quarter 2022 results
at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on
the Investor Relations section of CME Group’s website at www.cmegroup.com. An
archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables
clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data -
empowering market participants worldwide to efficiently manage risk and capture opportunities. CME
Group exchanges offer the widest range of global benchmark products across all major asset classes
based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The
company offers futures and options on futures trading through the CME Globex® platform, fixed income
trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of
the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow
Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones
Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC,
as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other
trademarks are the property of their respective owners.
- more -

-- 2 of 8 --

Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets
and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products
and services, including our ability to provide effective services to the swaps market; our ability to adjust our fixed
costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading
levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our
products and services; changes in regulations, including the impact of any changes in laws or government policies
with respect to our products or services or our industry, such as any changes to regulations and policies that require
increased financial and operational resources from us or our customers; the costs associated with protecting our
intellectual property rights and our ability to operate our business without violating the intellectual property rights
of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in
various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading
venue and the mix of customers (whether the customer receives member or non-member fees or participates in one
of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and
liquidity risk management practices to adequately protect us from the credit risks of clearing members and other
counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched
principal business; the ability of our compliance and risk management programs to effectively monitor and manage
our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security
breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and
exposure to risk through third parties, including risks related to the performance, reliability and security of
technology used by our third-party providers; volatility in commodity, equity and fixed income prices, and price
volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of
the capital and credit markets and the impact of economic conditions on the trading activity of our current and
potential customers; the impact of the COVID-19 pandemic and response by governments and other third parties;
our ability to accommodate increases in contract volume and order transaction traffic and to implement
enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to
execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs
and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those
associated with our investment in S&P/Dow Jones Indices LLC (S&P/DJI), our OSTTRA joint venture with IHS Markit
(now a part of S&P Global) and our partnership with Google Cloud; uncertainty related to the transition from
LIBOR; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest
in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a

-- 3 of 8 --

transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such
transactions; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal
proceedings. For a detailed discussion and additional information concerning these and other factors that might
affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year
ended December 31, 2021, as filed with the Securities and Exchange Commission ("SEC") on February 25, 2022,
under the caption "Risk Factors".
# # #

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
September 30, 2022 	December 31, 2021
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	2,130.1 	$ 	2,834.9
Marketable securities 	91.3 	115.0
Accounts receivable, net of allowance 	580.2 	434.5
Other current assets (includes $4.6 and $4.8 in restricted cash) 	476.4 	427.8
Performance bonds and guaranty fund contributions 	139,974.9 	157,949.6
Total current assets 	143,252.9 	161,761.8
Property, net of accumulated depreciation and amortization 	465.5 	505.3
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	3,302.2 	3,532.0
Goodwill 	10,447.3 	10,528.0
Other assets (includes $0.2 and $0.5 in restricted cash) 	3,788.3 	3,277.9
Total Assets 	$ 	178,431.5 	$ 	196,780.3
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	95.0 	$ 	48.8
Short-term debt 	14.5 	749.4
Other current liabilities 	488.3 	1,650.6
Performance bonds and guaranty fund contributions 	139,974.9 	157,949.6
Total current liabilities 	140,572.7 	160,398.4
Long-term debt 	3,421.8 	2,695.7
Deferred income tax liabilities, net 	5,351.5 	5,390.4
Other liabilities 	834.7 	896.5
Total Liabilities 	150,180.7 	169,381.0
Total CME Group Shareholders’ Equity 	28,250.8 	27,399.3
Total Liabilities and Equity 	$ 	178,431.5 	$ 	196,780.3

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended,
September 30,
2022 	2021 	2022 	2021
Revenues
Clearing and transaction fees 	$ 	998.6 	$ 	878.9 	$ 3,161.3 	$ 2,815.8
Market data and information services 	154.3 	145.4 	457.7 	434.8
Other 	74.9 	85.6 	192.6 	291.8
Total Revenues 	1,227.8 	1,109.9 	3,811.6 	3,542.4
Expenses
Compensation and benefits 	189.6 	198.6 	560.1 	635.3
Technology 	46.8 	49.3 	138.6 	146.8
Professional fees and outside services 	35.1 	45.2 	98.9 	119.4
Amortization of purchased intangibles 	55.5 	59.0 	171.0 	179.0
Depreciation and amortization 	34.5 	37.2 	101.0 	111.9
Licensing and other fee agreements 	83.6 	57.6 	247.6 	176.5
Other 	43.9 	49.3 	146.8 	160.0
Total Expenses 	489.0 	496.2 	1,464.0 	1,528.9
Operating Income 	738.8 	613.7 	2,347.6 	2,013.5
Non-Operating Income (Expense)
Investment income 	686.2 	145.8 	1,046.2 	239.1
Interest and other borrowing costs 	(40.4) 	(41.8) 	(122.8) 	(125.0)
Equity in net earnings of unconsolidated subsidiaries 	76.5 	66.4 	237.1 	178.3
Other non-operating income (expense) 	(581.1) 	311.8 	(845.1) 	268.4
Total Non-Operating Income (Expense) 	141.2 	482.2 	315.4 	560.8
Income before Income Taxes 	880.0 	1,095.9 	2,663.0 	2,574.3
Income tax provision 	200.4 	169.6 	609.9 	562.6
Net Income 	679.6 	926.3 	2,053.1 	2,011.7
Less: net (income) loss attributable to non-controlling interests 	— 	0.2 	— 	(0.5)
Net Income Attributable to CME Group 	$ 	679.6 	$ 	926.5 	$ 2,053.1 	$ 2,011.2
Net Income Attributable to Common Shareholders of CME
Group 	$ 	671.1 	$ 	926.5 	$ 2,027.2 	$ 2,011.2
Earnings per Share Attributable to Common Shareholders
of CME Group:
Basic 	$ 	1.87 	$ 	2.59 	$ 	5.65 	$ 	5.61
Diluted 	1.87 	2.58 	5.64 	5.60
Weighted Average Number of Common Shares:
Basic 	358,715 	358,363 	358,655 	358,258
Diluted 	359,288 	358,988 	359,206 	358,894

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
3Q 2021 	4Q 2021 	1Q 2022 	2Q 2022 	3Q 2022
Trading Days 	64 	64 	62 	62 	64
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	3Q 2021 	4Q 2021 	1Q 2022 	2Q 2022 	3Q 2022
Interest rates 	8,111 	9,805 	12,484 	10,630 	10,357
Equity indexes 	5,100 	5,943 	7,950 	7,751 	7,445
Foreign exchange 	776 	800 	904 	950 	1,091
Energy 	2,179 	2,252 	2,515 	1,932 	1,837
Agricultural commodities 	1,141 	1,216 	1,474 	1,308 	1,208
Metals 	480 	475 	593 	484 	498
Total 	17,786 	20,490 	25,920 	23,055 	22,437
Venue
CME Globex 	16,652 	19,043 	24,060 	21,531 	21,021
Open outcry 	598 	792 	1,030 	725 	704
Privately negotiated 	536 	656 	830 	799 	711
Total 	17,786 	20,490 	25,920 	23,055 	22,437
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	3Q 2021 	4Q 2021 	1Q 2022 	2Q 2022 	3Q 2022
Interest rates 	$ 	0.483 	$ 	0.487 	$ 	0.484 	$ 	0.493 	$ 	0.479
Equity indexes 	0.555 	0.526 	0.526 	0.532 	0.524
Foreign exchange 	0.803 	0.779 	0.800 	0.767 	0.729
Energy 	1.127 	1.111 	1.124 	1.171 	1.140
Agricultural commodities 	1.319 	1.323 	1.378 	1.411 	1.351
Metals 	1.463 	1.452 	1.482 	1.506 	1.520
Average RPC 	$ 	0.677 	$ 	0.650 	$ 	0.644 	$ 	0.647 	$ 	0.631
1. ADV and RPC includes futures and options on futures only.

-- 7 of 8 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended,
September 30,
2022 	2021 	2022 	2021
Net Income Attributable to CME Group 	$ 	679.6 	$ 	926.5 	$ 2,053.1 	$ 2,011.2
Restructuring and severance 	— 	6.6 	10.2 	25.8
Amortization of purchased intangibles(1) 	68.5 	63.1 	206.4 	183.1
Strategic transaction-related costs(2) 	1.2 	18.7 	3.4 	36.0
Foreign exchange transaction (gains) losses 	(10.5) 	(3.2) 	(23.6) 	0.2
Unrealized and realized (gains) losses on investments 	(1.1) 	(434.5) 	(4.6) 	(455.5)
Debt costs related to refinancing 	— 	— 	7.7 	—
Realized and unrealized losses on assets 	0.7 	0.5 	0.7 	1.7
Litigation matters 	— 	— 	— 	(3.1)
Trading floor enhancements 	— 	1.4 	4.8 	1.4
Income tax effect related to above 	(11.3) 	(0.8) 	(40.1) 	(34.1)
Other income tax items(3) 	(8.0) 	(3.9) 	(16.2) 	37.5
Adjusted Net Income Attributable to CME Group 	$ 	719.1 	$ 	574.4 	$ 2,201.8 	$ 1,804.2
Adjusted Net Income Attributable to Common
Shareholders of CME Group 	$ 	710.0 	$ 	574.4 	$ 2,174.1 	$ 1,804.2
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	1.87 	$ 	2.59 	$ 	5.65 	$ 	5.61
Diluted 	1.87 	2.58 	5.64 	5.60
Adjusted Earnings per Share Attributable to Common Shareholders of CME
Group:
Basic 	$ 	1.98 	$ 	1.60 	$ 	6.06 	$ 	5.04
Diluted 	1.98 	1.60 	6.05 	5.03
Weighted Average Number of Common Shares:
Basic 	358,715 	358,363 	358,655 	358,258
Diluted 	359,288 	358,988 	359,206 	358,894
Preferred shares(4) 	4,584 	— 	4,584 	—
1. Includes $10.6 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.4 million of
amortization of purchased intangibles at S&P/Dow Jones Indices LLC, reported in Equity in net earnings of
unconsolidated subsidiaries for the third quarter of 2022.
2. Strategic transaction-related costs primarily include professional fees related to the NEX integration.
3. Other income tax items include benefits recognized for the settlement of various tax audits.
4. Preferred shares have similar rights as common shares without voting rights.
22-102

-- 8 of 8 --